CSafe APS Data Sheet
The Pinnacle in Advanced Pallet Shipping
CSafe RKN Data Sheet
Single-Pallet Active Temperature Controlled Container
CSafe AX56L Data Sheet
Mobile Active
CSafe RAP Data Sheet
Multi-Pallet Active Temperature Controlled Container
Elevating Cell and Gene Therapy Logistics: 7 ways CSafe adds value outside the box
This article highlights seven key ways CSafe adds value outside the box across the pharmaceutical product life cycle.
CSafe expands its Cell & Gene Therapy portfolio with launch of high-performing CGT Ultra D
Latest dewar innovations will be showcased at the 2024 Cell & Gene Meeting on the Mesa event in Phoenix, Arizona Monroe, OH – October 3rd: CSafe, a global provider of end-to-end cold chain shipping solutions for the pharmaceutical industry, launches the CGT Ultra D – a multi-use, dry ice dewar built to meet the evolving […]
Rethinking logistics, the key barrier to scaling cell and gene therapies
This article discusses the critical role that logistics play in enabling patients to gain access to cell and gene therapies, and the steps pharma companies must take to scale up breakthrough discoveries to a viable commercial product offering.
CSafe Launches Reusable Silverpod Pallet Shipper to Help Pharma Companies Save on Disposal Costs and Hit Sustainability Targets
New pallet improves cost and operational efficiency while reducing environmental impact; includes real-time visibility with cloud connectivity Key features include: Made of fully reusable components and recyclable PCM (phase change material) refrigerants New integrated real-time tracking device tracks GPS location, temperature, shock and tilt Rental model reduces disposal costs and inconvenience, supported by CSafe’s recycle-reuse […]
Understanding Water-based and PCM Coolants
A CSafe white paper on the benefits of using water-based and PCM temperature control packaging systems.
Shipping Biologics: Maximized Safety With Minimized Costs
Facing continual challenges with passive Temperature Control Packaging (TCP) systems which were not performing as required, one leading global biopharmaceutical company needed to find a solution for transporting large quantities of biologics and immunotherapies – and one that could surmount a number of logistical challenges.
